Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for ...

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...

Spencer’s arrival at Eko comes months after the digital health company appointed his former colleague Brent Lang to its board ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

U.S. stock futures are little changed after indexes were mixed Monday; Nvidia stock adds to all-time high after CEO comments; ...

Stryker shares are currently trading up by 0.25%, with a current price of $362.34 as of Tuesday morning. This brings the total value of Boehnlein's 2,000 shares to $479,659.

Canaccord Genuity Group upped their price target on Stryker from $360.00 to $400.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Needham & Company LLC upped ...

Stryker has agreed to acquire medical technology maker Inari Medical in a deal worth $4.9 billion, the companies said Monday. The medical device maker plans to buy all of Inari's common stock for $80 ...

Analysts expect Stryker to earn $13.54 per share next year, which means the company should continue to be able to cover its $3.36 annual dividend with an expected future payout ratio of 24.8%.

When Billy Beane, general manager of the Oakland Athletics from 1997-2015, started using data analytics to build a winning ...